July 2026
Mescaline
What July 2026's 4 new studies found, synthesized from the papers below. All Mescaline research →
The synthesis
Synthesized from 3 studies in the library · AI-generated, grounded in the abstracts below
Found by searching the library for Mescaline, peyote, san pedro, huachuma, then ranked by relevance.
Research published in July 2026 on mescaline is limited and primarily descriptive or theoretical. A comprehensive review concludes that mescaline remains the only phenethylamine classic psychedelic, has the lowest 5-HT2A affinity, requires the highest doses, and lacks an adequate randomized controlled trial as of 2026. Other work focuses on peyote's cultural significance and conservation challenges rather than clinical effects. Thus, no new empirical findings on mescaline's efficacy or safety were reported in this period.
Evidence by study
Direction is which way each study's own result points, not our rating of the study. All 4 matching studies were reviewed; the 3 that directly address the question are shown here.
What the directions mean
- Supports:
- the study found the intervention worked, or its hypothesis held.
- Opposes:
- it found the opposite, no benefit or a harm.
- No effect:
- no significant difference either way.
- Mixed:
- effects in both directions within the same study.
- Unclear:
- the abstract does not report a direction.
| Study | Design | Sample size | Direction | Finding |
|---|---|---|---|---|
| Meskalin / Mescaline 2026 | review | Unclear | This transdisciplinary review argues that mescaline is the only phenethylamine classic psychedelic, has the lowest 5-HT2A affinity, requires the highest doses (hundreds of mg), has a dose-dependent duration of 6.4–14 hours, and lacks an adequate randomized controlled trial as of 2026. | |
| magnetismo del peyote 2026 | review | Unclear | This review describes the botany, chemistry, medicinal qualities, ecology, archaeology, history, and religious practices surrounding peyote, emphasizing its cultural importance to Indigenous peoples and highlighting alarming scarcity and conservation efforts. | |
| Der gezüchtete psychoaktive Pilz als Fall der Zugangs-Reorganisation — mit dem komparativen Fall des Peyote.** Transdisziplinäre Monografie (Ausbaustufe). Zweisprachig **DE + EN** 2026 | theoretical | Unclear | This theoretical paper argues that the cultivated psychoactive mushroom and peyote represent distinct cases of access reorganization, requiring comparative analysis of legal and cultural frameworks. |
This transdisciplinary review argues that mescaline is the only phenethylamine classic psychedelic, has the lowest 5-HT2A affinity, requires the highest doses (hundreds of mg), has a dose-dependent duration of 6.4–14 hours, and lacks an adequate randomized controlled trial as of 2026.
review
This review describes the botany, chemistry, medicinal qualities, ecology, archaeology, history, and religious practices surrounding peyote, emphasizing its cultural importance to Indigenous peoples and highlighting alarming scarcity and conservation efforts.
review
This theoretical paper argues that the cultivated psychoactive mushroom and peyote represent distinct cases of access reorganization, requiring comparative analysis of legal and cultural frameworks.
theoretical
Points of agreement
- Both reviews emphasize the cultural and ecological significance of peyote, particularly its role in Indigenous traditions and the need for conservation.
- The reviews agree that mescaline's clinical evidence base is weak, with no adequate randomized controlled trial as of 2026.
Conflicts
No notable conflicts.
Gaps
- No empirical studies on mescaline's clinical efficacy, safety, or dose-response were reported in July 2026.
- The reviews do not provide new data on mescaline's pharmacological effects in humans.
- Durability of effects, long-term outcomes, and specific patient populations remain unstudied in this period.